Pharmaceutical Investing CMS Grants Progenics New Technology Add-On Payment for Inpatient Use of AZEDRA
Pharmaceutical Investing Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy
Pharmaceutical Investing Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration
Pharmaceutical Investing Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
Pharmaceutical Investing Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer
Noble Mineral highlights Successful Exploration Results announced by Canada Nickel, including Highest Grade to Date at Mann West
CHARBONE Hydrogen and ABB Sign Agreement to Advance North American Green Hydrogen Production Facilities
